Department of Vascular Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Endocrinology, the Second Affiliated Hospital of Army Medical University, Choingqing, China.
Int Angiol. 2023 Aug;42(4):327-336. doi: 10.23736/S0392-9590.23.05064-2. Epub 2023 Jun 22.
This study aimed to investigate whether intravascular ultrasound (IVUS) combined with angiography during percutaneous transluminal angioplasty impacts treatment strategies and the 12-month patency of the femoropopliteal artery, compared to angiography alone.
This retrospective, single-center study enrolled 137 patients who underwent a femoropopliteal endovascular intervention between February 2020 and May 2021. Among these interventions, 43 were guided by IVUS combined with angiography and the remaining 94 were guided by angiography only. Treatment strategies and 12-month patency were analyzed in both groups. Multivariable analysis was performed to clarify the predictors of restenosis within 12 months.
Primary patency at 12 months was significantly higher in the IVUS group than in the angiography group (56.4% vs. 76.7%, P=0.047). The reference diameter on IVUS images was greater than that on angiography images. Therefore, the IVUS group presented a higher balloon-to-vessel ratio [1.0 (0.97, 1.01) vs. 1.06 (1.0.1.25)]. More adjunctive stents were required in the angiography group. However, more dissections were performed in the IVUS group, with no difference in flow-limiting dissections between groups. Target disease length (odds ratio 1.02, P=0.021) and balloon-to-vessel ratio (odds ratio 0.01, P=0.021) were independent predictors of restenosis.
Compared with angiography guidance alone, IVUS guidance for femoropopliteal artery-related treatment can significantly increase primary patency. This finding may be explained by the selection of larger balloons in IVUS and the resulting sufficient plaque compression and elastic membrane stretch. Moreover, IVUS was shown to detect more non-flow-limiting dissections than angiography.
本研究旨在探讨血管内超声(IVUS)联合经皮腔内血管成形术与单纯血管造影相比,是否会影响股腘动脉的治疗策略和 12 个月通畅率。
这是一项回顾性、单中心研究,共纳入 2020 年 2 月至 2021 年 5 月期间接受股腘动脉腔内介入治疗的 137 例患者。其中,43 例患者接受 IVUS 联合血管造影指导治疗,94 例患者仅接受血管造影指导治疗。分析两组患者的治疗策略和 12 个月通畅率。采用多变量分析明确 12 个月内再狭窄的预测因素。
IVUS 组 12 个月时的初始通畅率明显高于血管造影组(56.4%比 76.7%,P=0.047)。IVUS 图像上的参考直径大于血管造影图像上的直径。因此,IVUS 组的球囊-血管比更高[1.0(0.97,1.01)比 1.06(1.0.1.25)]。血管造影组需要更多的辅助支架,但 IVUS 组的夹层更多,但两组间的血流受限夹层无差异。靶病变长度(比值比 1.02,P=0.021)和球囊-血管比(比值比 0.01,P=0.021)是再狭窄的独立预测因素。
与单纯血管造影指导相比,IVUS 指导股腘动脉相关治疗可显著提高初始通畅率。这一发现可能与 IVUS 中选择更大的球囊,从而导致充分的斑块压缩和弹性膜拉伸有关。此外,IVUS 比血管造影更能检测到更多的非血流受限夹层。